Medicilon Logo
search icon search icon language icon contact icon menu icon
Medicilon Logo
search icon close search icon language icon contact icon menu icon
logo icon CN
Contact Us
Close Button
Back To Top
Online Message×
Click switch
Close Button
Medicilon's News information
News information

Reproductive Toxicity Test/Reproductive Toxicity Evaluation

Page View:

The reproductive toxicity test divides into sections I, section II, and section III reproductive toxicity test.

  • Part I reproductive toxicity test: also known as general reproductive toxicity test. The drug administers before the animal mating, and the purpose is to evaluate whether the germ cells have any adverse effects on the conception ability, the reproductive system, and the offspring after receiving the drug.

  • Part II Reproductive Toxicity Test: Teratogenic susceptibility period toxicity test. Administration during the organogenesis period aims to reveal the possible embryotoxicity and teratogenicity of the drug.

  • Part Ⅲ Reproductive toxicity test: also known as perinatal toxicity test. During the perinatal period and lactation period, the drug administers to observe the drug's effect on the growth and development of the fetus after birth.

We boast professional teams and practical experience in drug safety evaluation and can promise high-quality data and fast turnaround time to support various drug safety evaluation. Our toxicology research can be carried out according to non-GLP or GLP standards. Our research platform has been rated as Shanghai R&D Public Service Platform.

  • mouse

Main Research Content:

Test typeAnimal speciesType of drugAdministration routeResearch content
Reproductive toxicityRatsSmall molecules, biology, natural products, vaccines, Chinese medicineOral: gavage, capsules;
Parenteral: intraperitoneal injection, intravenous injection, intramuscular injection, intradermal injection, subcutaneous injection, continuous infusion, intravitreal injection;
Others: nasal feeding, nasal cavity, eyes, rectum, vagina, implantation
Ⅱ reproductive toxicity test

Reproductive Toxicity Research Service in Medicilon's Preclinical Service

Reproductive Toxicity Research Service in Medicilon’s Preclinical Service

Medicilon pursues comprehensive and accurate preclinical service goals for new drug research and development to improve the one-stop service and refine the one-stop platform. As a branch service platform of the preclinical department, the reproductive toxicity research platform is led by a professional technical team led by senior domestic reproductive toxicity experts to provide customers with more accurate non-clinical reproductive toxicity evaluations, which can promote the development of new drugs more quickly and effectively.

The reproductive toxicity test cycle is long and is greatly affected by experimental animals, experimental environments, experimental operators, and other factors. Therefore, professionals proficient in practical principles and skilled in technical operations must correctly complete experimental procedures in specific settings and accurately analyze experimental results. Medicilon's reproductive toxicity service team tries its best to avoid the influence of external factors on the objective consequences of the experiment to accurately evaluate the toxicity characteristics of the drug in the animal body, ensure better quality reproductive toxicity services, effectively save time and cost for customers, and effectively promote research and development process.

Medicilon's reproductive toxicity research service

Medicilon's reproductive toxicity research service platform personnel are composed of a professional technical team led by senior domestic reproductive toxicity experts with 30 years of research experience; the animal laboratory was jointly established by Medicilon and MPI Research (American Toxicology Research Company), Passed the International Laboratory Animal Evaluation and Approval (AAALAC) and reached the GLP dual standards of FDA and CFDA; the experimental instrument HamiltonThorne-TOX IVOS automatic sperm analyzer, imaging stereoscope, Leica microscope, etc. all meet the high-precision practical requirements; rich The complete equipment of resources gives Medicilon's reproductive toxicity research service platform a significant advantage in the industry, and can better ensure the quality and efficiency of the service.

Medicilon reproductive toxicity Research services

Medicilon reproductive toxicity Research services

Medicilon implements high-standard and strict service platform systems, hoping that every new medicine completed by Medicilon can enter the clinic more safely, be safer in the future market, and benefit patients more safely.

Contact Us


Related Articles:

Toxicity of ADC drugs
Drug Local Toxicity Test
Acute Toxicity Test/Detection/Evaluation

Relevant newsRelevant news